SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-007094
Filing Date
2023-01-26
Accepted
2023-01-26 17:49:09
Documents
1
Period of Report
2023-01-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm234575-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm234575-1_4seq1.xml 4 5406
  Complete submission text file 0001104659-23-007094.txt   7702
Mailing Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070
Business Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070 9732354295
ROCHE HOLDING LTD (Reporting) CIK: 0000889131 (see all company filings)

State of Incorp.: V8
Type: 4 | Act: 34 | File No.: 001-39138 | Film No.: 23558869
SIC: 8880 American Depositary Receipts

Mailing Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
Business Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
ROCHE FINANCE LTD (Reporting) CIK: 0001053942 (see all company filings)

State of Incorp.: V8
Type: 4 | Act: 34 | File No.: 001-39138 | Film No.: 23558868

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)